Abstract
The authors discuss the key challenges that undermine the control of Chagas disease and that must be urgently addressed to ensure long-term, sustainable control.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
Antiparasitic Agents / therapeutic use*
-
Chagas Cardiomyopathy / diagnosis
-
Chagas Cardiomyopathy / drug therapy*
-
Chagas Cardiomyopathy / epidemiology
-
Chagas Cardiomyopathy / prevention & control
-
Chagas Disease / diagnosis
-
Chagas Disease / drug therapy*
-
Chagas Disease / epidemiology
-
Chagas Disease / prevention & control
-
Chagas Disease / transmission
-
Communicable Disease Control
-
Disease Vectors
-
Humans
-
Orphan Drug Production*
-
Protozoan Vaccines*
-
Rare Diseases / diagnosis
-
Rare Diseases / drug therapy*
-
Rare Diseases / epidemiology
-
Rare Diseases / prevention & control
-
South America
-
Trypanosoma cruzi / immunology*
-
Trypanosoma cruzi / pathogenicity
Substances
-
Antiparasitic Agents
-
Protozoan Vaccines